Sacral Neuromodulation for Overactive Bladder
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
The Axonics SNM System has been shown to be a safe and effective treatment for overactive bladder, with studies indicating positive outcomes for patients with urinary urgency incontinence. The system is designed to last for at least 15 years, reducing the need for frequent replacements.
12345The Axonics Sacral Neuromodulation System is considered safe for treating overactive bladder and urinary urgency incontinence, with studies showing long-term safety and effectiveness. It is a rechargeable device approved by the FDA, designed to last at least 15 years, reducing the need for frequent replacement surgeries.
23567The Axonics SNM System is unique because it is the first rechargeable sacral neuromodulation device, designed to last at least 15 years, reducing the need for frequent replacement surgeries compared to non-rechargeable systems.
23468Eligibility Criteria
This trial is for men over 18 with an overactive bladder due to conditions like prostate cancer, benign prostatic hyperplasia, or after treatments like prostatectomy. Participants must have urinary urgency incontinence and be willing to attend follow-up assessments for a year.Inclusion Criteria
Participant Groups
- Urinary retention
- Overactive bladder symptoms including urinary urge incontinence and urgency-frequency
- Chronic fecal incontinence
- Urinary retention
- Overactive bladder symptoms including urinary urge incontinence and urgency-frequency
- Chronic fecal incontinence
- Overactive bladder symptoms including urinary urge incontinence and urgency-frequency
- Overactive bladder symptoms including urinary urge incontinence and urgency-frequency
- Faecal incontinence